-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
Pan-Asian clinical research coordination: challenges and opportunities
Karen Wai Kar Luen, Ken J Lee
Editorial: Clinical Investigation
-
Pan-Asian clinical research coordination: challenges and opportunities
Karen Wai Kar Luen, Ken J Lee
Editorial: Clinical Investigation
-
Pan-Asian clinical research coordination: challenges and opportunities
Karen Wai Kar Luen, Ken J Lee
Editorial: Clinical Investigation
-
Pan-Asian clinical research coordination: challenges and opportunities
Karen Wai Kar Luen, Ken J Lee
Editorial: Clinical Investigation
-
Pan-Asian clinical research coordination: challenges and opportunities
Karen Wai Kar Luen, Ken J Lee
Editorial: Clinical Investigation
-
Pan-Asian clinical research coordination: challenges and opportunities
Karen Wai Kar Luen, Ken J Lee
Editorial: Clinical Investigation
-
Pan-Asian clinical research coordination: challenges and opportunities
Karen Wai Kar Luen, Ken J Lee
Editorial: Clinical Investigation
-
Pan-Asian clinical research coordination: challenges and opportunities
Karen Wai Kar Luen, Ken J Lee
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation